ERIS LIFESCIENCES LTD.

NSE : ERISBSE : 540596ISIN CODE : INE406M01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE892.6010 (+1.13 %)
PREV CLOSE ( ) 882.60
OPEN PRICE ( ) 882.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2521
TODAY'S LOW / HIGH ( )877.00 896.40
52 WK LOW / HIGH ( )605.2 971
NSE892.959.35 (+1.06 %)
PREV CLOSE( ) 883.60
OPEN PRICE ( ) 884.60
BID PRICE (QTY) 892.95 (218)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 58767
TODAY'S LOW / HIGH( ) 875.00 897.30
52 WK LOW / HIGH ( )604.4 971.9
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax4046.434421.983944.973313.503173.58
Adjustment1398.39492.52440.72442.37305.01
Changes In working Capital-1755.36-299.0153.27-526.50-532.38
Cash Flow after changes in Working Capital3689.464615.494438.963229.372946.21
Cash Flow from Operating Activities2917.383782.643753.612711.662229.96
Cash Flow from Investing Activities-9821.01-3196.10-3233.581232.32-50.51
Cash Flow from Financing Activities6880.25-446.99-823.95-3345.91-2210.53
Net Cash Inflow / Outflow-23.38139.55-303.92598.07-31.08
Opening Cash & Cash Equivalents508.70369.15673.0775.00106.08
Cash & Cash Equivalent on Amalgamation / Take over / Merger74.90NANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent560.22508.70369.15673.0775.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.